Slides From Clinical Update on the Emerging Threat of Nontuberculous Mycobacterial Lung Disease

Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO

Daniel R. Kuritzkes, MD Released: March 19, 2020

Celine Gounder, MD, ScM, FIDSA: how healthcare providers can be prepared for when coronavirus comes to them. Testing for COVID-19, symptoms, screening, from CCO

Celine Gounder, MD, ScM, FIDSA Released: March 13, 2020

Interactive CCO video featuring expert discussion of current best practice for diagnosis and management of nontuberculous mycobacterial lung disease

Stephen Ruoss, MD Kevin L. Winthrop, MD, MPH ID Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: February 14, 2020 Expired: No longer available for credit

Overview (10 minutes)

Diagnosis (16 minutes)

First-line Treatment (15 minutes)

Defining Treatment Outcomes (10 minutes)

Treatment-Refractory NTM-LD (14 minutes)

Conclusions (2 minutes)